Mostrar el registro sencillo del ítem

dc.contributor.authorJiménez-Jiménez, F.J.*
dc.contributor.authorAlonso-Navarro, H.*
dc.contributor.authorGarcía-Martín, E.*
dc.contributor.authorSantos García, Diego *
dc.contributor.authorMartínez-Valbuena, I.*
dc.contributor.authorAgúndez, J.A.G.*
dc.date.accessioned2025-09-05T09:23:42Z
dc.date.available2025-09-05T09:23:42Z
dc.date.issued2023
dc.identifier.citationJiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Santos-García D, Martínez-Valbuena I, Agúndez JAG. Alpha-Synuclein in Peripheral Tissues as a Possible Marker for Neurological Diseases and Other Medical Conditions. Biomolecules. Multidisciplinary Digital Publishing Institute (MDPI); 2023;13(8).
dc.identifier.issn2218-273X
dc.identifier.otherhttps://portalcientifico.sergas.gal//documentos/64f635f466ccc641d10d7ea3
dc.identifier.urihttp://hdl.handle.net/20.500.11940/21043
dc.description.abstractThe possible usefulness of alpha-synuclein (aSyn) determinations in peripheral tissues (blood cells, salivary gland biopsies, olfactory mucosa, digestive tract, skin) and in biological fluids, except for cerebrospinal fluid (serum, plasma, saliva, feces, urine), as a marker of several diseases, has been the subject of numerous publications. This narrative review summarizes data from studies trying to determine the role of total, oligomeric, and phosphorylated aSyn determinations as a marker of various diseases, especially PD and other alpha-synucleinopathies. In summary, the results of studies addressing the determinations of aSyn in its different forms in peripheral tissues (especially in platelets, skin, and digestive tract, but also salivary glands and olfactory mucosa), in combination with other potential biomarkers, could be a useful tool to discriminate PD from controls and from other causes of parkinsonisms, including synucleinopathies.
dc.description.sponsorshipThe work at the authors' laboratory is supported in part by Grants PI18/00540 and PI21/01683 from Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Madrid, Spain, and IB20134 and GR21073 from Junta de Extremadura, Merida, Spain. Partially funded with FEDER funds.
dc.languageeng
dc.rightsAttribution 4.0 International (CC BY 4.0)*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshHumans *
dc.subject.meshalpha-Synuclein *
dc.subject.meshNervous System Diseases *
dc.subject.meshSynucleinopathies *
dc.subject.meshBody Fluids *
dc.subject.meshBiopsy *
dc.titleAlpha-Synuclein in Peripheral Tissues as a Possible Marker for Neurological Diseases and Other Medical Conditions
dc.typeArtigo
dc.authorsophosJiménez-Jiménez, F.J.; Alonso-Navarro, H.; García-Martín, E.; Santos-García, D.; Martínez-Valbuena, I.; Agúndez, J.A.G.
dc.identifier.doi10.3390/biom13081263
dc.identifier.sophos64f635f466ccc641d10d7ea3
dc.issue.number8
dc.journal.titleBiomolecules*
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Neuroloxía
dc.relation.projectIDFondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Madrid, Spain [PI18/00540, PI21/01683]
dc.relation.projectIDJunta de Extremadura, Merida, Spain [IB20134, GR21073]
dc.relation.projectIDFEDER funds
dc.relation.publisherversionhttps://doi.org/10.3390/biom13081263
dc.rights.accessRightsopenAccess*
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)
dc.typesophosArtículo de Revisión
dc.volume.number13


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution 4.0 International (CC BY 4.0)
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International (CC BY 4.0)